GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (CHIX:COLOBc) » Definitions » 3-Year Revenue Growth Rate

Coloplast AS (CHIX:COLOBC) 3-Year Revenue Growth Rate : 9.70% (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS 3-Year Revenue Growth Rate?

Coloplast AS's Revenue per Share for the three months ended in Mar. 2025 was kr30.75.

During the past 12 months, Coloplast AS's average Revenue per Share Growth Rate was 6.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Coloplast AS was 13.40% per year. The lowest was 3.60% per year. And the median was 7.80% per year.

Competitive Comparison of Coloplast AS's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Coloplast AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Coloplast AS's 3-Year Revenue Growth Rate falls into.


;
;

Coloplast AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Coloplast AS  (CHIX:COLOBc) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Coloplast AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Coloplast AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (CHIX:COLOBc) » Definitions » 3-Year Revenue Growth Rate
Comparable Companies
OCSE:DEMANT OCSE:AMBU B OCSE:GN OCSE:EMBLA OCSE:CHEMM OCSE:SMSMED OCSE:VIRO ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 XPAR:DIM XSWX:STMN COO BAX WST ALGN
Traded in Other Exchanges
CLPBY:USA CLPBF:USA 0QBO:UK COLO B:Denmark CBHD:Germany COLO:Austria
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Website
https://www.coloplast.com
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines